TVTX
#1191
Travere Therapeutics, Inc. - Common Stock
65.6 7 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.60%
Variación mensual
+19.79%
Variación en los últimos 6 meses
+124.28%
Cambio anual
+128.26%
Cierres anteriores
67.5 2
Open
65.6 7
Mínimo
65.6 7
Máximo
65.6 7
Volumen
119
Financials
- Market Capitalization 6.19 B
- Employee 497
- Founded 2011
- CEO N/A
- Website www.travere.com
- Headquarter California, United States
- FIGI BBG000P9D6W9
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-126.24
Relación precio/flujo de caja
9.08
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1117 |  SRRK Scholar Rock Holding Corporation - Common Stock | 57.80 USD | -2.46% | +0.49% | +21.81% | +92.54% | 7.04 B USD | ||
| 1184 |  MIRM Mirum Pharmaceuticals, Inc. - common stock | 96.72 USD | -0.76% | +0.22% | -8.14% | +37.92% | 6.28 B USD | ||
| 1213 |  ERAS Erasca, Inc. - Common Stock | 17.26 USD | -4.27% | -0.17% | -2.82% | +1006.41% | 6.04 B USD | ||
| 1220 |  LQDA Liquidia Corporation - Common Stock | 67.05 USD | -0.95% | -3.93% | -18.44% | +196.68% | 6.00 B USD |